A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection

Post-transplant or hematological cancer patients have a higher risk of mortality after infection with ancestral and early variants of severe acute respiratory syndrome (SARS)-CoV-2. Adoptive cell therapy (ACT) with virus-specific T cells (VSTs) could augment endogenous T cell immunity to avoid disea...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cytotherapy (Oxford, England) England), 2024-10, Vol.26 (10), p.1170-1178
Hauptverfasser:	Seng, Michaela Su-fern, Ng, King Pan, Soh, Teck Guan, Tan, Thuan Tong, Chan, Marieta, Maiwald, Matthias, Tan, Lip Kun, Linn, Yeh Ching, Leung, Wing
Format:	Artikel
Sprache:	eng
Schlagworte:	adoptive cell therapy COVID-19 hematopoietic stem cell transplant immunocompromised SARS-CoV2 specific T cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!